Clinical Trial Update: Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers [NA]

View source ↗

Summary

The clinical trial investigating acid sphingomyelinase/ceramide pathway activation in radiotherapy patients using IVIM diffusion-weighted MRI and serum biomarke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer to Bone
• Cancer to Soft Tissue

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Disease to Bone, Metastatic Disease to Soft Tissue | NA | Status: WITHDRAWN